197 related articles for article (PubMed ID: 12784553)
21. Bovine herpesvirus type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex.
Jones C; Chowdhury S
Vet Clin North Am Food Anim Pract; 2010 Jul; 26(2):303-21. PubMed ID: 20619186
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
[TBL] [Abstract][Full Text] [Related]
23. The use of marker vaccines in eradication of herpesviruses.
van Oirschot JT; Kaashoek MJ; Rijsewijk FA; Stegeman JA
J Biotechnol; 1996 Jan; 44(1-3):75-81. PubMed ID: 8717389
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
[TBL] [Abstract][Full Text] [Related]
25. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
[TBL] [Abstract][Full Text] [Related]
26. Intrapreputial infection of young bulls with bovine herpesvirus type 1.2 (BHV-1.2): acute balanoposthitis, latent infection and detection of viral DNA in regional neural and non-neural tissues 50 days after experimental reactivation.
Vogel FS; Flores EF; Weiblen R; Winkelmann ER; Moraes MP; Bragança JF
Vet Microbiol; 2004 Mar; 98(3-4):185-96. PubMed ID: 15036527
[TBL] [Abstract][Full Text] [Related]
27. BHV-1 infections in Styria (Austria) caused by intra-community trade.
Köfer J; Wagner P; Deutz A
Dtsch Tierarztl Wochenschr; 1999 Jun; 106(6):231-3. PubMed ID: 10422369
[TBL] [Abstract][Full Text] [Related]
28. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
Schynts F; Lemaire M; Ros C; Belak S; Thiry E
Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
[TBL] [Abstract][Full Text] [Related]
29. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period.
van Engelenburg FA; Kaashoek MJ; van Oirschot JT; Rijsewijk FA
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2387-92. PubMed ID: 7561782
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay.
Guarino H; Núñez A; Repiso MV; Gil A; Dargatz DA
Prev Vet Med; 2008 Jun; 85(1-2):34-40. PubMed ID: 18280598
[TBL] [Abstract][Full Text] [Related]
31. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of intranasally and parenterally administered infectious bovine rhinotracheitis vaccines.
McKercher DG; Crenshaw GL
J Am Vet Med Assoc; 1971 Dec; 159(11):1362-9. PubMed ID: 4341681
[No Abstract] [Full Text] [Related]
33. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1.
Gupta PK; Saini M; Gupta LK; Rao VD; Bandyopadhyay SK; Butchaiah G; Garg GK; Garg SK
Vet Microbiol; 2001 Feb; 78(4):293-305. PubMed ID: 11182496
[TBL] [Abstract][Full Text] [Related]
34. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
35. Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine.
Strube W; Abar B; Bergle RD; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Dev Biol Stand; 1995; 84():75-81. PubMed ID: 7796970
[TBL] [Abstract][Full Text] [Related]
36. Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E.
Fuchs M; Hübert P; Detterer J; Rziha HJ
J Clin Microbiol; 1999 Aug; 37(8):2498-507. PubMed ID: 10405392
[TBL] [Abstract][Full Text] [Related]
37. Genomic and pathogenic studies on a glycoprotein E variant field isolate of bovine herpesvirus 1.
Egyed L; Ros C; Belák S
Vet Res Commun; 2000 Sep; 24(6):423-31. PubMed ID: 11014611
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immune responses induced by BHV-1: rational vaccine design.
van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2007 Jun; 6(3):369-80. PubMed ID: 17542752
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a live bovine herpesvirus type 1 marker vaccine under field conditions in three countries.
Makoschey B; Zehle HH; Bussacchini M; Valla G; Pálfi V; Földi J
Vet Rec; 2007 Sep; 161(9):295-8. PubMed ID: 17766807
[TBL] [Abstract][Full Text] [Related]
40. Effect of levamisole and bovine interferon alpha 1 on bovine immune responses and susceptibility to bovine herpesvirus-1.
Babiuk LA; Ohmann HB
Prog Clin Biol Res; 1984; 161():433-42. PubMed ID: 6091152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
